Dr Reddy’s cancer drug hits the US market

Dr Reddy's Laboratories launches Docetaxel injection in the American market

id-100108224

Docetaxel is a generic version of Taxotere

Dr Reddy's Laboratories has launched Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, a generic version of Taxotere (docetaxel injection) in the US market.

According to the company, Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.

Taxotere (docetaxel) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X